New stent graft aims to fix Hard-to-Reach aneurysms while saving key arteries
NCT ID NCT05179967
First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time
Summary
This trial tests a special stent graft system designed to repair a complex type of abdominal aortic aneurysm that involves the arteries to the kidneys and gut. The device is placed inside the aorta using a minimally invasive procedure, aiming to seal the aneurysm while keeping blood flowing to vital organs. The study includes 106 adults aged 18 to 80 who need this type of repair. Researchers will check how safe the device is within 30 days and how well it works over 12 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- WeFlow-JAAA Stent Graft System
- What this could lead to
- If successful, this device could offer a less invasive way to treat complex abdominal aortic aneurysms that are hard to reach with standard surgery.
- What could go wrong
- This is an early-stage trial with 106 participants, so results may not apply to everyone. Risks include serious events like kidney failure, stroke, or bowel damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for JUXTARENAL ABDOMINAL AORTIC ANEURYSM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The General Hospital of the People's Liberation Army
Beijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.